BLK
69
2
ORLY
64
2
TSCO
55
-2
LEG
29
4
MCHP
42
-5
MPC
44
3
JPM
53
-2
AEP
59
-3
TRIP
60
3
ADSK
65
-2
D
55
-6
NRG
57
2
FRT
41
-2
PCG
74
-6
O
35
-2
GRMN
50
-2
ICE
64
-5
PLD
51
-5
LH
55
2
PG
51
-2
BLK
69
2
ORLY
64
2
TSCO
55
-2
LEG
29
4
MCHP
42
-5
MPC
44
3
JPM
53
-2
AEP
59
-3
TRIP
60
3
ADSK
65
-2
D
55
-6
NRG
57
2
FRT
41
-2
PCG
74
-6
O
35
-2
GRMN
50
-2
ICE
64
-5
PLD
51
-5
LH
55
2
PG
51
-2
Financhill
Back

Ocuphire Pharma Quote, Financials, Valuation and Earnings

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options
Sell
33

OCUP
Ocuphire Pharma

Last Price:
1.41
Seasonality Move:
-20.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager

Ocuphire Pharma Price Quote

$1.41
+0.08 (+6.02%)
(Updated: September 19, 2024 at 12:05 PM ET)

Ocuphire Pharma Key Stats

Sell
33
Ocuphire Pharma (OCUP) is a Sell
Day range:
$1.32 - $1.37
52-week range:
$1.15 - $4.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.94
P/B ratio:
0.86%
Volume:
89.2K
Avg. volume:
152.6K
1-year change:
-66.41%
Market cap:
$34.8M
Revenue:
$19M
EPS:
$-0.55

How Much Does Ocuphire Pharma Make?

Is Ocuphire Pharma Growing As A Company?

  • What Is Ocuphire Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.7%
  • What Is Ocuphire Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ocuphire Pharma Stock Price Performance

  • Did Ocuphire Pharma Stock Go Up Last Month?
    Ocuphire Pharma share price went up by 0% last month
  • Did OCUP's Share Price Rise Over The Last Year?
    OCUP share price fell by -66.41% over the past 1 year

What Is Ocuphire Pharma 52-Week High & Low?

Ocuphire Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ocuphire Pharma?

  • How Much Debt Does Ocuphire Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Ocuphire Pharma Have?
    Cash and short term investments quarterly total is $41.4M
  • What Is Ocuphire Pharma’s Book Value Per Share?
    Book value per share is 1.56

Is Ocuphire Pharma Cash Flow Positive?

  • What Is OCUP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$11.5M
  • What Is Ocuphire Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.9M
  • What Is Ocuphire Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Ocuphire Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    OCUP return on invested capital is -31.4%
  • What Is Ocuphire Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -28.41%
  • What Is OCUP Return On Equity?
    ROE is a measure of profitability and is -31.4%

Ocuphire Pharma Earnings Date & Stock Price

Ocuphire Pharma Competitors

  • Who Are Ocuphire Pharma's Competitors?
    Below is a list of companies who compete with Ocuphire Pharma or are related in some way:
    • Baxter International Inc (BAX)
    • Elanco Animal Health Inc (ELAN)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Syros Pharmaceuticals Inc (SYRS)

Ocuphire Pharma Dividend Yield

Ocuphire Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.26%
Revenue: -69.73% -42.75%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.75
Upside from Last Price: 1159.4%

Major Shareholders

  • How many OCUP shares are owned by institutional investors?
    3.9M OCUP shares are owned by institutional investors
  • How many OCUP shares are owned by insiders?
    2.6M OCUP shares are owned by insiders